How to Help Your Patients Find Dipyridamole in Stock: A Provider's Guide

When patients call to say they can't find Dipyridamole at their pharmacy, it creates a cascade of clinical and logistical challenges. The medication is critical for thromboembolism prophylaxis and stroke prevention, and gaps in therapy can carry real risk. This guide offers a structured approach for helping your patients maintain access to Dipyridamole — or transition safely to an alternative when needed.

Current Availability Landscape

Dipyridamole is available in multiple formulations, and availability varies across them:

• Oral tablets (25 mg, 50 mg, 75 mg): Generally available from generic manufacturers but not consistently stocked at all pharmacy locations, particularly chain pharmacies with low local demand.
• Injectable (5 mg/mL): Subject to active shortage per ASHP. Hikma's supply has been disrupted. This primarily affects cardiac stress testing protocols.
• Aggrenox (ASA 25 mg / Dipyridamole ER 200 mg): More consistently available than standalone tablets, though at higher cost. Not a 1:1 substitute since it includes Aspirin.

Why Patients Can't Find It

Understanding the root causes helps frame the conversation with patients and informs your sourcing strategy:

• Limited manufacturer base — Fewer generic companies produce Dipyridamole compared to high-volume generics, creating vulnerability when any single manufacturer has issues.
• Demand-based pharmacy stocking — Major chains use automated inventory systems that may not stock Dipyridamole at lower-volume locations, even when the drug is available from wholesalers.
• Supply chain concentration — Raw material sourcing for older generics is often concentrated among a few overseas suppliers, creating single points of failure.

What Providers Can Do: 5 Steps

Step 1: Verify the Availability Issue

Before changing therapy, confirm whether the issue is a true shortage or a local stocking gap. Ask the pharmacy whether they can order it from their wholesaler with a 1–2 day turnaround, or whether the drug is truly unavailable from their distributors. This distinction matters — a stocking issue can be solved by routing the prescription elsewhere, while a true shortage may require a therapeutic alternative.

Step 2: Direct Patients to Pharmacies with Stock

Use Medfinder for Providers to check which pharmacies in your area currently have Dipyridamole available. This tool can be used by your clinical staff at the point of prescribing to direct patients to a pharmacy that can fill immediately, rather than sending them on a frustrating search.

Step 3: Consider Independent Pharmacy Referrals

Independent pharmacies typically maintain relationships with multiple wholesalers and have greater flexibility to source hard-to-find medications. If your practice doesn't already have relationships with local independents, this is a good time to establish them. They can often special-order Dipyridamole within 24–48 hours when chains cannot.

Step 4: Prescribe with Flexibility

Consider writing prescriptions that give pharmacies some flexibility. For example, specifying "generic Dipyridamole" without a specific manufacturer allows the pharmacist to fill with whatever stock they can source. If appropriate for the patient, also consider whether Aggrenox (if available) could serve as a bridge.

Step 5: Have an Alternative Ready

If Dipyridamole truly cannot be sourced, be prepared to switch therapy. Per current guidelines:

• For stroke prevention: Clopidogrel 75 mg daily or Aspirin 50–325 mg daily (AHA/ASA 2021 guidelines).
• For heart valve prophylaxis: Evaluate whether warfarin anticoagulation alone provides adequate protection, or consider adding low-dose Aspirin based on individual risk assessment.
• For stress testing: Regadenoson (Lexiscan) or Adenosine as pharmacological stressor alternatives.

Workflow Tips for Your Practice

Integrating medication availability awareness into your workflow reduces patient callbacks and therapy gaps:

• Check availability at the point of prescribing — Before sending a prescription electronically, have staff check Medfinder to verify the patient's preferred pharmacy has the medication, or suggest an alternative that does.
• Proactively counsel patients on early refills — Encourage patients to refill Dipyridamole 5–7 days before running out, giving the pharmacy time to order if needed.
• Document backup plans in the chart — For patients on Dipyridamole, note the preferred alternative therapy in case of future shortages. This allows any covering provider to make the switch quickly.
• Establish pharmacy relationships — Build relationships with 2–3 independent pharmacies that reliably source less common generics. A quick call to a trusted pharmacist can resolve what seems like an impossible fill.

Final Thoughts

Medication access is increasingly part of the provider's role, whether we like it or not. By building shortage awareness into your prescribing workflow and leveraging tools like Medfinder for Providers, you can reduce the burden on your patients and keep therapy uninterrupted. For the latest shortage data, see our Dipyridamole shortage briefing for providers.